Patents by Inventor Alan Shaw
Alan Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240111083Abstract: Described examples include an apparatus includes a dichroic wedge and a spatial light modulator optically coupled to the dichroic wedge. The apparatus also includes a display optically coupled to the spatial light modulator. The display includes a waveguide having a first side and a second side and a first diffractive optical element on the first side of the waveguide. The display also includes a second diffractive optical element on the first side of the waveguide and a third diffractive optical element on the second side of the waveguide.Type: ApplicationFiled: December 12, 2023Publication date: April 4, 2024Inventors: Terry Alan Bartlett, Stephen Aldridge Shaw, Vivek Kumar Thakur
-
Patent number: 11947670Abstract: Examples of the present disclosure describe systems and methods for malicious software detection based on API trust. In an example, a set of software instructions executed by a computing device may call an API. A hook may be generated on the API, such that a threat processor may receive an indication when the API is called. Accordingly, the threat processor may generate a trust metric based on the execution of the set of software instructions, which may be used to determine whether the set of software instructions poses a potential threat. For example, one or more call stack frames may be evaluated to determine whether a return address is preceded by a call instruction, whether the return address is associated with a set of software instructions or memory associated with a set of software instructions, and/or whether the set of software instructions satisfies a variety of security criteria.Type: GrantFiled: January 2, 2023Date of Patent: April 2, 2024Assignee: Open Text IncInventors: Andrew L. Sandoval, David Alan Myers, John R. Shaw, II, Eric Klonowski
-
Patent number: 11912721Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6, 7-dihydro-7, 14-methanobenzimidazo[1, 2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.Type: GrantFiled: November 24, 2020Date of Patent: February 27, 2024Assignees: UCB Biopharma SRL, SanofiInventors: Teresa De Haro Garcia, Michael Deligny, Jag Paul Heer, Joanna Rachel Quincey, Mengyang Xuan, Zhaoning Zhu, Daniel Christopher Brookings, Mark Daniel Calmiano, Yves Evrard, Martin Clive Hutchings, James Andrew Johnson, Sophie Jadot, Jean Keyaerts, Malcolm MacCoss, Matthew Duncan Selby, Michael Alan Shaw, Dominique Louis Leon Swinnen, Laurent Schio, Yann Foricher, Bruno Filoche-Romme
-
Publication number: 20230340401Abstract: The present disclosure provides methods of combining methanotrophic bacterial biomass production with a methanation process, comprising: (a) culturing a methanotrophic bacterium in the presence of methane and oxygen to produce biomass and carbon dioxide; and (b) generating methane using the carbon dioxide produced in step (a) and hydrogen. Also provided are systems that comprise: (a) one or more bioreactors comprising a culture of a methanotrophic bacterium to produce biomass and carbon dioxide in the presence of methane, and (b) one or more reactors for generating methane, wherein the system is configured so that the carbon dioxide generated from reactor (a) is fed into reactor (b).Type: ApplicationFiled: December 5, 2022Publication date: October 26, 2023Inventors: Alan SHAW, Lorraine Joan GIVER
-
Publication number: 20210155637Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.Type: ApplicationFiled: November 24, 2020Publication date: May 27, 2021Inventors: Teresa De Haro Garcia, Michael Deligny, Jag Paul Heer, Joanna Rachel Quincey, Mengyang Xuan, Zhaoning Zhu, Daniel Christopher Brookings, Mark Daniel Calmiano, Yves Evrard, Martin Clive Hutchings, James Andrew Johnson, Sophie Jadot, Jean Keyaerts, Malcolm Mac Coss, Matthew Duncan Selby, Michael Alan Shaw, Dominique Louis Leon Swinnen, Laurent Schio, Yann Foricher, Bruno Filoche-Romme
-
Patent number: 10906919Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.Type: GrantFiled: December 14, 2018Date of Patent: February 2, 2021Assignees: UCB Biopharma SRL, SanofiInventors: Teresa De Haro Garcia, Michael Deligny, Jag Paul Heer, Joanna Rachel Quincey, Mengyang Xuan, Zhaoning Zhu, Daniel Christopher Brookings, Mark Daniel Calmiano, Yves Evrard, Martin Clive Hutchings, James Andrew Johnson, Sophie Jadot, Jean Keyaerts, Malcolm Mac Coss, Matthew Duncan Selby, Michael Alan Shaw, Dominique Louis Leon Swinnen, Laurent Schio, Yann Foricher, Bruno Filoche-Romme
-
Publication number: 20190367535Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.Type: ApplicationFiled: December 14, 2018Publication date: December 5, 2019Inventors: Teresa De Haro Garcia, Michael Deligny, Jag Paul Heer, Joanna Rachel Quincey, Mengyang Xuan, Zhaoning Zhu, Daniel Christopher Brookings, Mark Daniel Calmiano, Yves Evrard, Martin Clive Hutchings, James Andrew Johnson, Sophie Jadot, Jean Keyaerts, Malcolm Mac Coss, Matthew Duncan Selby, Michael Alan Shaw, Dominique Louis Leon Swinnen, Laurent Schio, Yann Foricher, Bruno Filoche-Romme
-
Patent number: 10445407Abstract: In various embodiments, methods and systems, for automatically generating guides, are provided. A user can generate guides based on content zones of a wireframe layout or visual element layout. A selection of a content zone having a shape is received. A selection of a guide creation action to generate a grid structure encompassing the shape of the content zone is received. A determination of a boundary set for the shape is made. The boundary set includes a top boundary, a bottom boundary, a left boundary, and a right boundary. The boundary set is based on a data (e.g., vector, pixel, text) perimeter of the shape. The grid structure is automatically generated based on the shape. The grid structure comprises a top horizontal guide, a bottom horizontal guide, a left vertical guide, and right vertical guide. The grid structure is located adjacent to portions of the boundary set of the shape.Type: GrantFiled: July 20, 2015Date of Patent: October 15, 2019Assignee: Adobe Inc.Inventors: Seth Alan Shaw, Alan Lee Erickson
-
Patent number: 10202405Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.Type: GrantFiled: October 2, 2015Date of Patent: February 12, 2019Assignee: UCB Biopharma SPRLInventors: Teresa De Haro Garcia, Michael Deligny, Jag Paul Heer, Joanna Rachel Quincey, Mengyang Xuan, Zhaoning Zhu, Daniel Christopher Brookings, Mark Daniel Calmiano, Yves Evrard, Martin Clive Hutchings, James Andrew Johnson, Sophie Jadot, Jean Keyaerts, Malcolm Mac Coss, Matthew Duncan Selby, Michael Alan Shaw, Dominique Louis Leon Swinnen, Laurent Schio, Yann Foricher, Bruno Filoche-Romme
-
Patent number: 10052506Abstract: Two-sided and two-sided mirrored fire barriers having each of their two sides tested, rated, and certified for use in common spaces, such as spaces shared between two rooms are taught. Two-sided barriers require only one barrier and one installation, instead of the two presently needed. Two-sided barriers may have different construction and composition on each side; whereas each side of a mirrored fire barrier is a mirror image of the other. All two-sided barriers include top-mounted, bottom-mounted, and side-mounted barriers, gas and moisture impermeable barriers, and barriers shaped to fit into the expansion joint spaces created when a plurality of expansion joints intersect. The barriers are disposed to various sizes, lengths, widths, and depths, in addition to variations in shape, content, number and composition of layers, materials, and attachment means required to accommodate the variety of sizes and shapes of expansion-joint spaces and the desired rating, in terms of hours.Type: GrantFiled: April 10, 2011Date of Patent: August 21, 2018Assignee: InPro CorporationInventor: Alan Shaw
-
Patent number: 10004737Abstract: A series of substituted benzimidazole, imidazo[1,2-?]pyridine and pyrazolo[1,5-?]pyridine derivatives, and analogs thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.Type: GrantFiled: December 8, 2014Date of Patent: June 26, 2018Assignee: UCB BIOPHARMA SPRLInventors: Julien Alistair Brown, Mark Daniel Calmiano, Elizabeth Pearl Jones, Boris Kroeplien, James Thomas Reuberson, Matthew Duncan Selby, Michael Alan Shaw, Zhaoning Zhu
-
Patent number: 9949933Abstract: Various fenofibrate dosage forms contain a plurality of beads or particles, where the beads or particles include a pharmaceutical composition comprising fenofibrate; from 0.3% to 10% by weight of the beads or particles of a surfactant; and from about 5% to about 15% by weight of the beads or particles of a water soluble or water dispersible cellulosic binder. The mass ratio of the drug to the binder in the dosage form is between about 3.5:1 and 4.5:1; and the dosage form produces a first Cmax in vivo that is between about 10% and about 50% higher than a comparative Cmax produced by a comparative dosage form. The comparative dosage form comprises the drug and the binder in a ratio of between about 5:1 and 15:1. The dosage form may contain a plurality of beads or particles, each of the beads or particles including a pharmaceutical composition containing from about 20% to about 55% by weight of fenofibrate; from 0.Type: GrantFiled: July 29, 2016Date of Patent: April 24, 2018Assignee: Mylan Inc.Inventors: Sarat C. Chattaraj, Glenn Allen Redelman, Andrew Alan Shaw
-
Patent number: 9868749Abstract: A series of substituted benzimidazole, imidazo[1,2-a]pyridine and pyrazolo[1,5-a]pyridine derivatives, and analogues thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.Type: GrantFiled: December 8, 2014Date of Patent: January 16, 2018Assignee: UCB BIOPHARMA SPRLInventors: Rikki Peter Alexander, Jonathan Mark Bentley, Gareth Neil Brace, Daniel Christopher Brookings, Prafulkumar Tulshibhai Chovatia, Hervé Jean Claude Deboves, Craig Johnstone, Elizabeth Pearl Jones, Boris Kroeplien, Fabien Claude Lecomte, James Madden, Craig Miller, John Robert Porter, Matthew Duncan Selby, Michael Alan Shaw, Darshan Gunvant Vaidya, Ian Andrew Yule
-
Patent number: 9845597Abstract: A fire barrier assembly includes a fire barrier, mounting elements and securement elements. The mounting elements are positioned along the length of the fire barrier on an inner surface of the fire barrier. The mounting elements engage one or more of the securement elements to the fire barrier. When installed within an expansions space, the securement elements are used to tension mount the fire barrier assembly securely and generally immovably within the expansion space, without the need for any mechanical, adhesive, or other fixed connection to anchor the fire barrier assembly in place. As such, no modification to the building structures defining the expansion space (e.g. no drilling holes, applying adhesive, etc.) is need to mount the fire barrier assembly. If desired, the fire barrier assembly may easily be detached and removed from the expansion space.Type: GrantFiled: March 8, 2017Date of Patent: December 19, 2017Assignee: InPro CorporationInventors: Alan Shaw, George Matthew Fisher, Matthew G. Bennett
-
Publication number: 20170305932Abstract: A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.Type: ApplicationFiled: October 2, 2015Publication date: October 26, 2017Inventors: Teresa De Haro Garcia, Michael Deligny, Jag Paul Heer, Joanna Rachel Quincey, Mengyang Xuan, Zhaoning Zhu, Daniel Christopher Brookings, Mark Daniel Calmiano, Yves Evrard, Martin Clive Hutchings, James Andrew Johnson, Sophie Jadot, Jean Keyaerts, Malcolm Mac Coss, Matthew Duncan Selby, Michael Alan Shaw, Dominique Louis Leon Swinnen, Laurent Schio, Yann Foricher, Bruno Filoche-Romme
-
Publication number: 20170128445Abstract: A series of substituted benzimidazole, imidazo[1,2-?]pyridine and pyrazolo[1,5-?]pyridine derivatives, and analogues thereof, being potent modulators of human TNF? activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.Type: ApplicationFiled: December 8, 2014Publication date: May 11, 2017Inventors: Julien Alistair Brown, Mark Daniel Calmiano, Elizabeth Pearl Jones, Boris Kroeplien, James Thomas Reuberson, Matthew Duncan Selby, Michael Alan Shaw, Zhaoning Zhu
-
Publication number: 20170024361Abstract: In various embodiments, methods and systems, for automatically generating guides, are provided. A user can generate guides based on content zones of a wireframe layout or visual element layout. A selection of a content zone having a shape is received. A selection of a guide creation action to generate a grid structure encompassing the shape of the content zone is received. A determination of a boundary set for the shape is made. The boundary set includes a top boundary, a bottom boundary, a left boundary, and a right boundary. The boundary set is based on a data (e.g., vector, pixel, text) perimeter of the shape. The grid structure is automatically generated based on the shape. The grid structure comprises a top horizontal guide, a bottom horizontal guide, a left vertical guide, and right vertical guide. The grid structure is located adjacent to portions of the boundary set of the shape.Type: ApplicationFiled: July 20, 2015Publication date: January 26, 2017Inventors: SETH ALAN SHAW, ALAN LEE ERICKSON
-
Patent number: D848036Type: GrantFiled: March 13, 2017Date of Patent: May 7, 2019Assignee: InPro CorporationInventors: Alan Shaw, George Matthew Fisher, Matthew G. Bennett
-
Patent number: D887587Type: GrantFiled: March 11, 2019Date of Patent: June 16, 2020Assignee: InPro CorporationInventors: Alan Shaw, George Matthew Fisher, Matthew G. Bennett
-
Patent number: D888290Type: GrantFiled: March 11, 2019Date of Patent: June 23, 2020Assignee: InPro CorporationInventors: Alan Shaw, George Matthew Fisher, Matthew G. Bennett